Position in LH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$438,635
+$5,868 QoQ
Shares Held
1,644
-4.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Curi Capital, LLC holds $113,657,199 across 14 Diagnostics & Research names. LH ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
280,064 | $53,100,133 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
57,201 | $32,140,669 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
46,597 | $22,903,822 | |
| 4 | VCYT |
Veracyte, Inc.
|
44,060 | $1,419,171 | |
| 5 | ILMN |
Illumina, Inc.
|
6,666 | $821,651 | |
| 6 | NEO |
Neogenomics Inc
|
85,323 | $633,096 | |
| 7 | GRAL |
GRAIL, Inc.
|
9,006 | $465,429 | |
| 8 | LH |
Labcorp Holdings Inc.
This page
|
1,644 | $438,635 |
All Filings in LH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $438,635 | 1,644 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $432,767 | 1,725 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $472,787 | 1,647 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $429,465 | 1,636 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $366,954 | 1,642 | Shares | Sole | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||